Genpharmasec Peer Comparison

BSE: 531592

₹1.03

₹0.03 (3.00%)

As on 28-Aug-2026IST

Market cap

₹57 Cr

Revenue (TTM)

₹178 Cr

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Market cap (₹ Cr)	57	43,670	18,189	16,726	16,656
Revenue (₹ Cr)	178	3,634	12,104	15,120	16,177
Net Profit (₹ Cr)	-0.83	789.70	984.94	-2,079.00	642.99
Net Margin (%)	-0.46	21.23	8.08	-13.50	3.84
RoE (%)	-0.18	21.00	14.73	-0.68	16.10
Price to Earnings	--	55.30	18.48	--	25.90
Price-To-Book	0.86	10.40	2.48	0.79	3.87

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Operating Revenue	177.60	3,633.58	12,103.54	15,120.00	16,176.50
Total Income	180.44	3,720.05	12,188.72	15,396.00	16,245.41
Total Expenditure	176.37	2,401.62	10,087.37	13,409.00	15,224.06
EBITDA	1.24	1,231.96	2,016.17	1,711.00	952.44
Depreciation	2.58	155.64	425.46	1,257.00	151.54
EBIT	-1.34	1,076.32	1,590.71	454.00	800.90
Interest	1.52	119.62	359.41	591.00	20.30
Other Income	2.84	86.47	85.18	276.00	68.91
Exceptional Items	0.00	-6.75	0.00	-1,956.00	0.00
Profit before Tax	-0.02	1,036.42	1,316.48	-1,817.00	849.51
Provision for Tax	0.81	246.72	331.54	262.00	225.84
Profit after Tax	-0.83	789.70	984.94	-2,079.00	623.67

Liabilities (₹ Cr)

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Shareholder's Funds	66.27	3,974.58	6,844.57	21,206.00	3,957.46
Minority Interest	0.71	0.00	-0.82	-194.00	0.00
Non-Current Liabilities	25.48	1,336.49	4,597.39	10,113.00	202.83
Current Liabilities	47.03	1,068.05	4,426.39	6,743.00	4,275.35
Total Liabilities	--	5,289.07	12,904.76	37,750.00	--

Assets (₹ Cr)

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Non-Current Assets	50.52	3,407.09	9,285.58	30,035.00	838.53
Current Assets	80.52	2,785.38	6,031.10	7,206.00	7,225.21
Total Assets	--	5,289.07	12,904.76	37,750.00	--
Total Debt*	--	1,440.73	3,932.71	6,304.00	--
Net Current Assets	33.50	1,717.33	1,604.71	463.00	2,949.86
Contingent Liabilities	--	12.37	1,871.11	1,189.00	--

Cashflow (₹ Cr)

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Cash From Operating Activities	--	570.81	1,879.66	1,761.00	--
Cash Flow from Investing Activities	--	-511.07	-1,061.51	-1,681.00	--
Cash from Financing Activities	--	-46.70	-688.97	29.00	--
Net Cash Inflow / Outflow	--	13.04	129.18	109.00	--

Ratios

Profitability Ratios

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
ROCE (%)	--	11.76	16.22	3.93	--
ROE (%)	-0.18	21.00	14.73	-0.68	16.10
ROA (%)	-0.76	14.09	6.65	-5.41	7.38
EBIT Margin (%)	-0.75	29.62	13.14	3.00	4.95
Net Margin (%)	-0.46	21.23	8.08	-13.50	3.84
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Revenue Growth (%)	337.77	42.43	13.63	2.04	9.43
EBIT Growth (%)	-762.58	110.14	1.84	-49.44	67.20
Net Profit Growth (%)	-134.63	122.72	-0.40	-688.95	52.29
EPS Growth (%)	-105.07	117.02	0.30	-133.00	55.89
Book Value Growth (%)	--	10.08	12.54	-2.91	--

Valuation Ratios

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Price / Earnings	-471.40	54.86	18.42	-112.99	26.71
Price / Book Value	0.86	10.40	2.48	0.79	3.87
Dividend Yield (%)	0.00	0.18	0.70	1.68	0.65
EV/EBITDA	44.32	35.37	11.41	13.26	16.57
Market Cap (₹ Cr)	--	20,873.30	14,078.01	22,059.56	--

Solvency Ratios

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Debt to Equity	0.36	0.24	0.60	0.22	0.00
Short term debt to equity ratio	--	0.11	0.04	0.08	--
Current Ratio	1.71	2.61	1.36	1.07	1.69
Quick Ratio	1.42	2.19	0.97	0.61	1.06
Interest Coverage	0.99	9.66	4.66	-2.07	42.85

Operating Efficiency Ratios

	Genpharmasec	Navin Fluorine	Deepak Fertilisers	Tata Chemicals	BASF India
Debtors to sales (%)	16.48	20.69	19.36	13.81	16.90
Asset Turnover	1.63	0.65	0.82	0.39	1.91
Receivable days	--	85.05	49.96	43.55	--
Inventory Days	--	53.92	36.53	58.24	--
Payable days	--	113.74	56.34	273.43	--
Cash Conversion Cycle	--	25.23	30.14	-171.65	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.